Allianz Asset Management
TARO

Allianz Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Allianz Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,973
Closed -$1.33M – 2694
2016
Q3 		$1.33M Buy
11,973
+100
+0.8% +$13.2K ﹤0.01% 2133
2016
Q2 		$1.73M Buy
11,873
+9,473
+395% +$1.34M ﹤0.01% 1990
2016
Q1 		$344K Buy
+2,400
New +$341K ﹤0.01% 2324

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's TARO Position: Q4 2016 in Review

Allianz Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 11,973 shares — an estimated $1.33M sold.

Allianz Asset Management first reported a position in TARO in Q1 2016 and held it in 3 quarters. The position peaked at $1.73M in Q2 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • Allianz Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
  • Allianz Asset Management sold 11,973 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $1.33M.
  • Allianz Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 3 quarters.
  • Allianz Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.73M in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.